Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced that it will report financial results for the first quarter 2024 on Thursday, May 9, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET.
Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations.
Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Companytm, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.
RaySearch will be showcasing its latest software innovations at ESTRO in Glasgow, May 3-6. Attendees will be able to book demonstrations of the treatment planning system RayStation®*, the oncology information system RayCare®*, and the cloud-based...
Forum will be held on May 30 at the Science Museum, LondonChaired by Professor Sir Munir Pirmohamed, Forum to consist of four panel sessions highlighting solutions to pressing issues facing private and public-sector innovators in the healthcare...
Clarivate Plc , a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligencetm solution, featuring a new post-approval variations module. The module for post-approval variations...
Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting,...
Today, 2 May 2024, is the last day of trading in unit rights in SciBase Holding AB (publ) ("SciBase" or the "Company") rights issue of units of up to approximately SEK 15 million (the "Rights Issue"). The Rights Issue was resolved by the Board of...
SciBase Holding AB ("SciBase") (STO: SCIB), a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the...
